The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 136.00
Bid: 135.80
Ask: 136.20
Change: -0.10 (-0.07%)
Spread: 0.40 (0.295%)
Open: 137.40
High: 137.60
Low: 134.30
Prev. Close: 136.10
AML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of shares and total voting rights

2 Nov 2023 08:00

RNS Number : 1147S
Aston Martin Lagonda Glob.Hldgs PLC
02 November 2023

2 November 2023

Aston Martin Lagonda Global Holdings plc

("Aston Martin" or the "Company")

Progress to completion of Lucid Transaction and Admission of Consideration SharesTotal Voting Rights

Further to its announcement on 19 September 2023 confirming the receipt of shareholder approvals in connection with the strategic supply arrangement with Lucid Group, Inc. ("Lucid") (the "Transaction"), Aston Martin is today pleased to announce that clearance from all applicable regulatory and antitrust authorities has been obtained and the Transaction can proceed to completion.

Accordingly, the Company announces that, subject and pursuant to the previously disclosed terms of the Transaction:

· 28,352,273 new ordinary shares of £0.10 each in its share capital (the "Consideration Shares") will be allotted and issued to Lucid's subsidiary, Atieva, Inc.

· Integration and supply agreements between Aston Martin and Lucid governing Aston Martin's access to certain of Lucid's industry-leading technologies, including electric powertrains and battery systems, will become effective from Admission of the Consideration Shares

Applications have been made to the Financial Conduct Authority (the "FCA") and the London Stock Exchange plc (the "LSE") respectively for the admission of the Consideration Shares to listing on the premium listing segment of the Official List of the FCA and to trading on the main market for listed securities of the LSE (together, "Admission"). It is expected that Admission will become effective at 8.00 a.m. on 6 November 2023.

In accordance with the FCA's Disclosure Guidance and Transparency Rules, the Company also notifies that, following Admission becoming effective, the total issued share capital of the Company will be 823,663,785 ordinary shares of £0.10 each with one voting right per share. There are no ordinary shares held in treasury.

Therefore, following Admission becoming effective, the total number of voting rights in the Company will be 823,663,785 and this figure should be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Enquiries

Investors and Analysts

Robert Berg Director of Investor Relations +44 (0) 7833 080458

robert.berg@astonmartin.com

Ella South Investor Relations Analyst +44 (0) 7776 545420

ella.south@astonmartin.com

Media

Kevin Watters Director of Communications +44 (0)7764 386683

kevin.watters@astonmartin.com

Paul Garbett Head of Corporate & Brand Communications +44 (0)7501 380799

paul.garbett@astonmartin.com

Teneo

Harry Cameron +44 (0)20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ALSFFFIILALLIIV
Date   Source Headline
28th Sep 20227:00 amRNSResults of Rights Issue and Total Voting Rights
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20224:35 pmRNSPrice Monitoring Extension
14th Sep 20224:38 pmRNSHolding(s) in Company
14th Sep 20229:49 amRNSHolding(s) in Company
14th Sep 20229:46 amRNSHolding(s) in Company
14th Sep 20227:00 amRNSRights Issue offer period amended
13th Sep 20229:00 amRNSHolding(s) in Company
12th Sep 20227:00 amRNSAdmission of Nil Paid Rights
9th Sep 20227:00 amRNSAdmission of placing shares & total voting rights
8th Sep 202211:32 amRNSResult of General Meeting
5th Sep 202212:28 pmRNSPublication of Prospectus
5th Sep 20227:00 amRNS4 for 1 c.£575.8 million Rights Issue
22nd Aug 20227:00 amRNSCircular and Notice of General Meeting
29th Jul 20227:00 amRNSHalf-year Report
15th Jul 20227:00 amRNSProposed New Equity Financing and Investment
1st Jul 20223:37 pmRNSHolding(s) in Company
1st Jul 202211:38 amRNSHolding(s) in Company
30th Jun 20223:31 pmRNSStatement Regarding Media Commentary
20th Jun 20221:20 pmRNSCompany Secretary Change
14th Jun 20227:00 amRNSDirector/PDMR Shareholding
25th May 202212:04 pmRNSResult of AGM
11th May 20227:00 amRNSHolding(s) in Company
4th May 20227:01 amRNS1st Quarter Results
4th May 20227:00 amRNSAppointment of New Chief Executive Officer
3rd May 20227:00 amRNSNew Chief Financial Officer Joins Board
28th Apr 20223:14 pmRNSHolding(s) in Company
25th Apr 20222:08 pmRNSNotice of AGM
20th Apr 202212:19 pmRNSDirector Declaration
31st Mar 20227:00 amRNSDirector/PDMR Shareholding
14th Mar 20227:02 amRNSChief Financial Officer Board Appointment Date
14th Mar 20227:00 amRNSPublication of 2021 Annual Report and Accounts
28th Feb 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20227:00 amRNSFinal Results
2nd Feb 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSDirectorate Change
7th Jan 20227:00 amRNSFY 2021 Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSDirector/PDMR Shareholding
17th Dec 202110:01 amRNSDirector/PDMR Shareholding
2nd Dec 20213:07 pmRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSDirectorate Change
1st Dec 202110:19 amRNSAdditional Listing
29th Nov 202110:53 amRNSDirector/PDMR Shareholding
24th Nov 20212:00 pmRNSDirector/PDMR Shareholding
12th Nov 202110:30 amRNSDirector/PDMR Shareholding
8th Nov 202110:49 amRNSDirector/PDMR Shareholding
4th Nov 20217:05 amRNSResults for the nine months to 30 September 2021
29th Oct 202110:02 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.